Inventor · disambiguated record
Leon M. Smith, Ii
Also filed as: SMITH II LEON M · SMITH LEON · SMITH LEON M · SMITH LEON M II
41 granted patents·9 pending applications·256 citations·filing 2001–2022
97Inventor score
Top patents by PatentIndex Score
50 records- 0196US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0295US8367709B2Dipeptide analogs as coagulation factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 5, 2013·42 cites·11 claims
- 0394US9192607B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Nov 24, 2015·7 cites·11 claims
- 0493US9000172B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Apr 7, 2015·7 cites·19 claims
- 0592US9902742B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 27, 2018·5 cites·13 claims
- 0692US9611274B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 4, 2017·5 cites·14 claims
- 0792US6995162B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Feb 7, 2006·48 cites·26 claims
- 0891US9221818B2Macrocycles as factor XIa inhibitorsPINTO DONALD J P·Filed 2012·Granted Dec 29, 2015·13 cites·11 claims
- 0991US7626039B2Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 1, 2009·14 cites·14 claims
- 1090US7514564B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2006·Granted Apr 7, 2009·16 cites·15 claims
- 1189US9944625B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 17, 2018·3 cites·14 claims
- 1287US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 1387US7105682B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 12, 2006·29 cites·17 claims
- 1486US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 1586US8642624B2Substituted alkylamine derivatives and methods of useCHEN GUOQING·Filed 2011·Granted Feb 4, 2014·11 cites·3 claims
- 1685US7101868B2Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Granted Sep 5, 2006·20 cites·36 claims
- 1784US9108951B2Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Aug 18, 2015·5 cites·6 claims
- 1883US7842708B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 30, 2010·4 cites·16 claims
- 1979US9447110B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 20, 2016·1 cites·1 claims
- 2078US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 2177US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 2277US10000466B2Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 19, 2018·1 cites·5 claims
- 2374US10336730B2Substituted glycine derived FXIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 2, 2019·1 cites·10 claims
- 2474US9409908B2Dihydropyridone p1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 9, 2016·1 cites·14 claims
- 2573US10611776B2Spiroheptane salicylamides and related compounds as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 7, 2020·1 cites·17 claims
- 2669US10208021B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 19, 2019·0 cites·3 claims
- 2766US9738655B2Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·1 cites·15 claims
- 2864US8901115B2Cyclic P1 linkers as factor XIa inhibitorsLAM PATRICK Y S·Filed 2012·Granted Dec 2, 2014·1 cites·12 claims
- 2963US10899743B2Substituted glycine derived FXIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 3062US2016318904A1Substituted tetrahydroisoquinoline compounds as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3159US10273236B2Macrocyclic factor XIa inhibitors bearing heterocyclic groupsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 30, 2019·0 cites·11 claims
- 3258US10829501B2Spiroheptane salicylamides and related compounds as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 10, 2020·0 cites·5 claims
- 3358US9725435B2Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 8, 2017·0 cites·5 claims
- 3458US8604056B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitorsPINTO DONALD J P·Filed 2012·Granted Dec 10, 2013·0 cites·5 claims
- 3558US2013273004A1Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 3658US2025011288A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3758US2025221966A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3857US2005153960A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 3956US9108981B2Cyclic P1 linkers as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 18, 2015·0 cites·11 claims
- 4055US9394276B2Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 19, 2016·0 cites·5 claims
- 4154US9951071B2Dihydropyridone P1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 24, 2018·0 cites·7 claims
- 4254US2017342071A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4353US8252830B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitorsPINTO DONALD J P·Filed 2010·Granted Aug 28, 2012·0 cites·4 claims
- 4447US9315519B2Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 19, 2016·0 cites·18 claims
- 4546US2017057961A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4645US9403774B2Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 2, 2016·0 cites·17 claims
- 4744US9079929B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Jul 14, 2015·0 cites·11 claims
- 4841US2002147198A1Substituted arylamine derivatives and methods of useFiled 2002·Application pending·0 cites
- 4939US10160750B2Diamide macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 25, 2018·0 cites·14 claims
- 5038US2002173507A1Urea compounds and methods of usesFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →